About Getein Biotech,Inc Company

The company (stock code 603387) was founded in March 2002, is headquartered in Nanjing, and listed on the main board of the Shanghai Stock Exchange in July 2017. Currently, the company has more than 300 authorized patents and a total of more than 1,120 independent product registration certificates at home and abroad, covering various fields such as cardiovascular disease, kidney damage, diabetes, pregnancy, infectious diseases, and tumors, and is widely used in medical institutions at all levels. The company has focused on R&D, production, sales and service of in vitro diagnostic reagents and instruments for more than 20 years. The company's main products are Poct reagents, chemiluminescence reagents, coagulation reagents, POCT (immune quantitative analyzer FIA8000, fluorescence immunity quantitative analyzer Getein1100, fluorescence immunity quantitative analyzer Getein1200, etc.) instruments, biochemical instruments (fully automatic biochemical analyzer CM400, etc.), chemiluminescence instruments (fully automatic chemiluminescence analyzer MAGICL6000, etc.), etc. Corporate honors: Enterprise honors Nanjing Enterprise Technology Center, Advanced In-vitro Diagnosis Production Unit, National Torch Program Key High-tech Enterprise, etc.